Skip to main content
Clinical Trials/NL-OMON40188
NL-OMON40188
Recruiting
N/A

A randomized clinical trial of ultrasound-guided double percutaneous needling versus high-energy extracorporeal shockwave therapy in the treatment of calcific tendinopathy of the rotator cuff. - nvt

Spaarne Ziekenhuis0 sites100 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
calcific tendinopathy
Sponsor
Spaarne Ziekenhuis
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Spaarne Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years
  • Clinical signs of subacromial impingement of the shoulder
  • Symptoms persisting for more than four months
  • Unsuccessful conservative therapy within the previous four months. (Physiotherapy, radiotherapy, infiltration with local anaesthetics and/or steroids, anti\-inflammatory drugs)
  • Standardised radiographs showing calcific deposits with a diameter of at least 5 mm. (Morphological type\-I and type\-II deposits corresponding to the classification of Gartner and Simons on radiographs: Type I, sharply outlined and densely structured. Type II, sharply outlined and inhomogenous or homogenous with no defined border)

Exclusion Criteria

  • Evidence of full\-thickness tears of the rotator cuff on physical examination, ultrasound images or MRI.
  • Radiological signs of spontaneous resorption of the deposit and type\-III deposits according to the classification of Gartner and Simons: Type III, cloudy and transparent in structure.
  • Calcific deposits in multiple tendons of the rotator cuff.
  • Acute subacromial/subdeltoid bursitis.
  • Osteoarthritis of the glenohumeral or acromioclavicular joint.
  • Previous surgery to the shoulder.
  • Adhesive capsulitis
  • Instability of the shoulder.
  • ESWT / barbotage within the last year.
  • Reumatoid arthritis.

Outcomes

Primary Outcomes

Not specified

Similar Trials